glp 1 agonist liraglutide GLP-1 Agonists for Weight Loss: Safe or Risky? Generic Liraglutide (Victoza) Becomes First
Description
The population in SELECT was different that STEP-1 and SUMOUNT 1, with 90.1% of patients on lipid-lowering therapy and a much lower baseline LDL-C of 78 mg/dL compared to 111 mg/dL and 110 mg/dL in STEP-1 and SURMOUNT 1 respectively [33, 35, 48]
A., Cavaiola, T
As semaglutide is an already clinically approved drug, successful human trials would hasten its inclusion into therapeutic treatment of NASH and neurodegenerative diseases
A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes
